FDA approves Aqneursa for NPC

September 24, 2024 FDA approves Aqneursa for NPC Yesterday, the FDA approved AQNEURSA, a second therapy for NPC patients. This approval highlights the power of collaboration and partnership. For the…Read More

Read More
FDA approves Miplyffa for NPC

September 25, 2024 FDA approves Miplyffa for NPC Today is a monumental day for the NPC Community and the first thing Chris and I wanted to do was share it…Read More

Read More